ThyCa Awards 6 Thyroid Cancer Research Grants
09/2023September 14, 2023—ThyCa is excited to announce six thyroid cancer research grants, for projects that center on follicular cell thyroid cancer (papillary, follicular, poorly differentiated, and anaplastic thyroid cancer), and medullary thyroid cancer.
The new ThyCa grants were awarded to researchers at Albert Einstein College of Medicine, New York, NY, Stanford University School of Medicine, Stanford, CA, and University of Cincinnati, Cincinnati, OH.
This is the twenty-first consecutive year of ThyCa research grants. The grants are funded through donations to ThyCa from thyroid cancer patients, family members, and friends. ThyCa grants are open to researchers and institutions worldwide. Independent expert panels of the American Thyroid Association (ATA) and American Association of Endocrine surgeons (AAES) reviewed applications and recommended the recipients of these six grants with ThyCa making the final selections.
The New ThyCa Grant Recipients through the ATA:- Chandrayee Ghosh, PhD, Stanford University School of Medicine, Stanford, CA. Her project is titled "Combination auranofin and BRAF inhibition treatment in BRAFV600E mutant anaplastic thyroid cancer." This grant is the Ric Blake Memorial Thyroid Cancer Research Grant, named in honor of one of ThyCa's Co-Founders.
- George Karagiannis, DVM, PhD, Albert Einstein College of Medicine, Bronx, NY. His project is titled "Exploiting the midkine-driven embryonic reprogramming in anaplastic thyroid carcinoma."
The New ThyCa Grant Recipient through the AAES:
Tammy Holm, MD, PhD, University of Cincinnati, Cincinnati, OH. Her project is titled "Targeted autophagy in the pathogenesis of anaplastic thyroid cancer."
The Continuation of 2022 ThyCa Grants Recipients through the ATA:
- Iñigo Landa, PhD, Brigham and Women’s Hospital, Boston, MA. His project is titled "Therapeutic vulnerabilities of telomerase-reactivated thyroid cancers." This grant is the Ric Blake Memorial Thyroid Cancer Research Grant, named in honor of one of ThyCa's Co-Founders.
- Theodora Pappa, MD, PhD, Brigham and Women's Hospital, Boston, MA. Her project is titled "Dissecting the immune programs driving thyroid cancer progression."
- Julio Ricarte Filho, PhD, Children's Hospital of Philadelphia, Philadelphia, PA. His project is titled "Integrative genomic and transcriptomic analysis of MEN2B-associated MTC."
“Thank you to the generous donations from our ThyCa supporters who make these grants possible,” said ThyCa Executive Director Gary Bloom, himself a thyroid cancer survivor. “We are grateful to all our donors for your generosity and commitment to pursuing our mission and vision of educating and supporting the global thyroid cancer community and investing in research so we can pursue a world free of thyroid cancer.”
Learn more about ThyCa’s research grant program.
ThyCa provides a wide array of free services and resources to everyone affected by a thyroid cancer diagnosis since 1995. These include thyroid cancer support groups in three countries; one-to-one support available worldwide; educational events including seminars, workshops, webinars, and the annual International Thyroid Cancer Survivors’ Conference www.thyca.org/conference; free publications including handbooks on all types of thyroid cancer, monthly online newsletter, low-iodine diet cookbook, a patient information packet, and thyroid cancer awareness materials; and pediatric sportpacks with information for children and teens with thyroid cancer and their families.
ThyCa’s comprehensive educational web site has content in 12 languages: English, Arabic, Chinese, French, Greek, Hebrew, Italian, Japanese, Portuguese, Russian, Spanish, and Ukrainian.
ThyCa receives guidance from its Medical Advisory Council of more than 50 world-recognized experts in the field of thyroid cancer. ThyCa sponsors Thyroid Cancer Awareness Month in September, a worldwide observance, plus year-round awareness campaigns. Details are available on ThyCa’s website, by calling 1-877-588-7904 or emailing thyca@thyca.org.